Humanwell Healthcare (Group) Co.,Ltd. (SHA:600079)
China · Delayed Price · Currency is CNY 20.80
+0.03 (0.14%)
Oct 27, 2025, 11:29 AM CST
SHA:600079 Revenue
Humanwell Healthcare (Group) had revenue of 5.93B CNY in the quarter ending June 30, 2025, a decrease of -8.74%. This brings the company's revenue in the last twelve months to 24.64B, down -1.46% year-over-year. In the year 2024, Humanwell Healthcare (Group) had annual revenue of 25.44B with 3.71% growth.
Revenue (ttm)
24.64B
Revenue Growth
-1.46%
P/S Ratio
1.38
Revenue / Employee
1.40M
Employees
17,650
Market Cap
33.90B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 25.44B | 910.74M | 3.71% |
| Dec 31, 2023 | 24.52B | 2.19B | 9.79% |
| Dec 31, 2022 | 22.34B | 1.79B | 8.71% |
| Dec 31, 2021 | 20.55B | -131.18M | -0.63% |
| Dec 31, 2020 | 20.68B | -1.13B | -5.17% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Huadong Medicine | 42.62B |
| WuXi AppTec | 41.90B |
| Yunnan Baiyao Group Co.,Ltd | 40.84B |
| Shanghai Fosun Pharmaceutical (Group) | 40.12B |
| Shenzhen Mindray Bio-Medical Electronics | 32.94B |
| Jiangsu Hengrui Medicine | 30.15B |
| Zhejiang NHU Company | 22.87B |
| Aier Eye Hospital Group | 21.94B |